Executive Leadership

Chief Medical Officer

about

The Partner
We Worked With

Our partner is a clinical-stage company developing a novel class of myeloid checkpoint inhibitors. The company brings significant drug discovery and development expertise to this challenge, complementary to over a decade of research by academic collaborators, to evaluate the role of this family of receptors in cancer.

objectives

The Need
We Filled

This executive leader played a critical role in shaping our partner’s strategy, while interfacing with investors and partners. They cultivated the existing pipeline and maneuvered preclinical assets through the clinical process. They also managed an IND for the lead candidate (treatment of Acute Myeloid Leukemia -AML) in Q2 2020.

key metrics

Proven, measurable
results

STAT. 1
3

days until hired candidate presented

STAT. 2
8

candidates presented

STAT. 3
37

days until search completed

Record of Success

Related case studies